Advanced Animal Diagnostics develops diagnostic equipment for dairy farmers to identify infections and inform antibiotic usage. Its flagship product, the QScout MLD (milk leukocyte differential), tests and identifies white blood cells in milk and looks for data that could signify infection. The company positions its technology to help farmers monitor herd health more precisely and reduce unnecessary antibiotic use. Financially, the company recently raised capital via a debt offering and disclosed additional capital needs in an SEC filing. Joy Parr Drach has served as president and CEO since 2009 and previously founded Entira, a marketing strategy and business development firm. The article does not disclose revenues, users, or other operating metrics. Advanced Animal Diagnostics builds diagnostic tools designed to detect and determine the stage of livestock infections by measuring the animal's immune response. The technology is intended to help reduce the number of antibiotics administered to animals on farms. The company is based in North Carolina. It recently secured a $1.7 million equity top-up financing from existing investors. Those investors had committed to the company's $15 million Series C in December 2014, including Cultivian Sandbox, Kansas Bioscience Authority, and Middleland Capital. According to CrunchBase, the company has raised a total of $36 million to date. Advanced Animal Diagnostics develops on-farm diagnostic technologies to help livestock producers manage animal health and costly diseases. Its core products include the QScout MLD test and QScout Farm Lab, which detect subclinical mastitis in dairy cows and help prevent milk and reproductive losses. The company says its tests also safeguard animal health and promote more judicious use of antibiotics. AAD intends to use new funding to accelerate commercialization of its current QScout MLD offering and to expand its product line by advancing development of additional livestock tests for dairy and beef markets. The company also plans to invest in production and manufacturing to support commercialization. AAD is led by president and CEO Joy Parr Drach and is based in Durham, N.C. Advanced Animal Diagnostics (AAD) develops on-farm diagnostic systems and tests intended to improve animal health and ensure a high-quality animal protein supply. Its core product line centers on the Qscout™ automated on-farm lab system and the Qscout™ MLD rapid on-farm test for mastitis in dairy cows. The company’s first product is a rapid, on-farm diagnostic test for faster, more accurate detection of subclinical mastitis. All tests on the market or in development at AAD are processed by the Qscout automated reader so producers can run multiple tests on the same instrument. AAD plans to launch the Qscout system and Qscout MLD test, develop new tests to detect disease-causing pathogens, and study use of the Qscout MLD test at other times during lactation. The company is based in Durham, NC and recently closed financing to support these initiatives. Advanced Animal Diagnostics (AAD) develops highly accurate, rapid on-farm diagnostic tests, with its first product focused on early detection of mastitis to improve milk production and quality. The company commercialized the QuickSmear™ rapid differential slide for researchers in 2009 and is targeting on-farm tests that work on colostrum to enable immediate treatment. Future product plans include diagnostics to monitor disease states, reproductive, nutritional and overall health status of production animals. AAD was founded in 2001 and began with a USDA SBIR grant and subsequent funding from the North Carolina Biotechnology Center. The firm previously raised a $1.1 million Series A from private investors. Proceeds from the recent financing are expected to support hiring, production and manufacturing, and on-farm economic trials of its first product line; the company is actively seeking cooperators for those trials.

Total raised

$37M

Funding rounds

5

Latest round

Debt Financing

Latest activity

Jan 2018